Deeply inspiring lecture by Pat LoRusso AACR president 🤍 #MCCR24 is a 360 degrees experience for mentors and mentees: network, science, brainstorming - we never stop learning EORTC ESMO - Eur. Oncology OncoAlert Nadia Harbeck,MD PhD Benjamin Besse Marta Perachino ChiaraMolinelli

So touching and inspiring lecture🥹 no better way to close this #MCCR24 EORTC ESMO - Eur. Oncology thank you for have made it possible ⭐️

Standing ovation for Pat LoRusso here at #MCCR2024! Such an inspiring woman! AACR ESMO - Eur. Oncology

Don’t miss OncoAlert newsletter this week 👇🏻👇🏻

stage I TNBC no neo/adjCT sTIL >50% had better BCSS vs <50% (HR, 0.27; 95% CI, 0.10-0.74) ↗️TILs correlated with excellent 10-y BCSS 🔍further need to evaluate sTILs as integral biomarkers in prospective trials of tp optimization ⁦OncoAlert⁩ jamanetwork.com/journals/jamao…

Tra i 7 italiani vincitori del prestigioso ASCO Conquer Cancer Merit Award c'è anche Luca Arecco, MD, specializzando del Ospedale San Martino Genova e @Unige. La sua ricerca sul tumore al seno mira a identificare biomarcatori per predire la prognosi delle giovani pazienti con mutazione BRCA.

Buena suerte Diletta Favero ❤️❤️🥹

What a team!!! 🤩🔝 OncoAlert

Happy 4️⃣July with OncoAlert newsletter 🤩💥 👇🏻👇🏻 subscribe at the link below

⭐️ESMO recommendation for genomic testing in solid cancer 👇🏻 check out annalsofoncology.org/article/S0923-… OncoAlert

Out now OncoAlert newsletter 📥 Rectal, renal, páncreas, lung and breast cancer are the main topics⭐️ 🩻🫁🏃🏼‍♀️ Don’t miss it 👇🏻 oncoalert.m-pages.com/nhMpwe/oncoale…

Really honored and grateful for the opportunity to visit Vall d’Hebron Institute of Oncology (VHIO) and discuss the special challenges in the care of #BreastCancer in young women…muchas gracias Cristina Saura & judith balmaña for the kind invitation!!! OncoAlert Università di Genova Ospedale San Martino Genova Marta Perachino

📣 New VHIO- CaixaResearch Scientific Seminar‼️   🔹 Breast cancer in young women 👨‍🔬 Matteo Lambertini, MD PhD, Università di Genova & Ospedale San Martino Genova 🗓 19th July at 12h 📍 Cellex Auditorium  Host: Cristina Saura & judith balmaña ➕ linke.to/MatteoLamberti…

Identifican un biomarcador que ayuda a seleccionar a las pacientes que más responden a patritumab deruxtecán, uno de los últimos fármacos revolucionarios en #CáncerMama. 🗞️ Publicado en Nature Communications ➡️ linke.to/TOT-HER3VHIO #TOTHER3

Wrap up of a day of the highest level science ⭐️🤩 Thanks Matteo Lambertini, MD PhD for joining us providing your expertise 🍕🍔a lot of food for thought &… a lot of work to do!!💪🏻 🙂‍↔️let’s make all of these exciting projects happen☄️ Vall d’Hebron Institute of Oncology (VHIO) Università di Genova judith balmaña Cristina Saura

Sequencing SG➡️TZP in mTNBC - proof of mechanism study 🏅 mPFS of 7.6 months without DLT vs concurrent dosing yielded 2.3 months PFS and multiple DLTs including severe myelosuppression 🔍sequential dosing of SG➡️TZP can📈 synergy ⁦OncoAlert⁩ aacrjournals.org/clincancerres/…

🔬 El Grupo de Cáncer de Mama del VHIO se especializa en la investigación clínica enfocada en el desarrollo de fármacos y la investigación traslacional asociada. 👩‍🔬 Descubre quiénes son 👉linke.to/CancerMamaVHIO #ClínicaVHIO

Which is the most prescribed adjuvant ET in premenopausal patients? And which criteria determine this choice? We published in The Breast Online first insights from #GIM23 study answering some of these questions! thebreastonline.com/article/S0960-… OncoAlert 🧶

🏄🏼‍♀️Diving into latest algorithm modifications in treatment of metastatic BC with such a ⭐️stellar⭐️faculty Cristina Saura Lucia Del Mastro Barbara Pistilli G Curigliano MD PhD So proud to be part of both teams Università di Genova Vall d’Hebron Institute of Oncology (VHIO) 🦾🥰 #W4O #ESMO2024

Outstanding Matteo Lambertini, MD PhD discussing a crucial aspect in survivorship: fertility preservation and consequences of cancer treatments on fertility and future pregnancies 👏🏻🤰🏻 📌A topic we should always take into account when counseling a young pt💁🏼‍♀️ #ESMO24 Università di Genova